Ann: MDC Extends NanoCelle Platform to Anti-Malaria Drug, page-2

good to see it done as proof of concept. Just more evidence that nanocelle can succesfully utilised for many drugs etc. obviously it's nothing material and likely never will be. and as sean stated in his last proactive investors interview, this malaria drug is outside their remit and they were asked to do it. However once nanocelle has gone through the full patent defense procedure, this is the type of evidence that will make it a potentially large commercial asset. it's drugs like these with adverse side-effects where something like nanocellle is crucial if there is no safer drug alternative.